Form 8-K MAIA Biotechnology, Inc. For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
MAIA Biotechnology (MAIA) Suspends Common Stosk Sales
November 15, 2023 8:49 AM ESTOn November 15, 2023, MAIA Biotechnology (NYSE: MAIA) suspended sales of its common stock, par value $0.0001 per share (Common Stock), pursuant to that certain Sales Agreement, dated as of September 1, 2023 (the Sales Agreement), between the Company and ThinkEquity LLC (the Agent), the Companys sales agent thereunder, and... More
